MCP Server For Financial Data by EODHD Learn more

Tempest Therapeutics Inc icon

Tempest Therapeutics Inc (TPST NASDAQ) stock market data APIs

$0.3432 0.03(8.7%)
as of November 16, 2026
Try our APIs with free plan!

Tempest Therapeutics Inc Financial Data Overview

Price chart is built with Anychart

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study; and has a product development and investigator-initiated trial collaboration agreement with Heibei Senlang Biotechnology Co., Ltd. to develop TPST-4003 product candidate. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.

Prev. Close 0.3432
Open 0.3779
High 0.3886
Low 0.3432
52 wk Range 0.337-9.2468
Market Cap 6 834 K
Shares Outstanding 19 995 K
EPS -0.21
Beta -1.562

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Tempest Therapeutics Inc (top by weight)

Ticker
100-day Price Change
Weight
VXF.US Vanguard Extended Market Index Fund ETF Shares
-21.18 (-8.58%)
0.00
VTI.US Vanguard Total Stock Market Index Fund ETF Shares
-16.52 (-4.34%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Tempest Therapeutics Inc data using free add-ons & libraries


Get Tempest Therapeutics Inc Fundamental Data

Tempest Therapeutics Inc logo

Tempest Therapeutics Inc Fundamental data includes:

  • Net Revenue:
  • EBITDA: -20 648 000
  • Earnings Per Share: -3
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Tempest Therapeutics Inc Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-11-13
  • EPS/Forecast: -0.32
GET THE PACKAGE

Get Tempest Therapeutics Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Tempest Therapeutics Inc News

Get Tempest Therapeutics Inc fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.